SUBSCRIBE
SUBSCRIBE
News   Drug Development

Almirall Prodesfarma Key Drug Trials Disappoint Investors

September 3, 2008 | 
1 min read
MADRID, Sept 3 (Reuters) - Spanish drug firm Almirall said the results of advanced trials for its key lung disease drug showed it was less effective than in previous trials, sending shares plummeting 18 percent.
Clinical research Phase II Asia Europe
MORE ON THIS TOPIC
Business people shaking hand in China.
China
Hengrui Licenses Heart Disease Drug to US Startup for up to $1B+
September 5, 2025
 · 
2 min read
 · 
Tristan Manalac
halftone magazine style banner, dislike, negative rating, hand thumbs down
FDA
FDA Drops Another Cache of Heavily Redacted Rejection Letters, Promises Future ‘Real-Time’ Access
September 4, 2025
 · 
4 min read
 · 
Annalee Armstrong
IN PARTNERSHIP WITH TACONIC BIOSCIENCES
The ‘Research Safety Net’ Saving Scientists from Funding Crisis
September 4, 2025
 · 
1 min read
 · 
Lori Ellis
Sea wave. Hand drawn realistic vector illustration in oriental vintage ukiyo-e style.
RNA editing
Wave Crashes Despite Successful RNA Editing in AATD Study
September 4, 2025
 · 
2 min read
 · 
Tristan Manalac